摘要
背景:静息态功能磁共振成像(RS-fMRI)出现作为一种很有前途的成像技术可鉴别阿尔茨海默型神经退行性疾病。该技术可检测这种疾病的早期阶段比结构的改变更敏感。最近研究发现在轻度认知障碍发现有趣状态,变更(MCI)阿尔茨海默病的前驱期的静息状态的活性。然而,它已经不作为是否RS-fMRI的改变可能是任何在个体水平和是否来自RS fMRI图像参数添加任何定量预测/分类价值标准认知测试(CTS)的诊断使用。方法:我们计算了一套基于rs-fMRI 444特征并使用21个变量从一个神经心理测试评估电池在29例MCI患者和21例健康对照。我们用这些指标来评价其对MCI/正常使用机器学习算法分类和10折交叉验证分析的影响。结果:使用这两套指标,分类精度(灵敏度/特异性/面积曲线下/阳性预测值、阴性预测值)0.9559(0.9620/0.9470/0.9517/0.9720/0.9628)是可以实现。使用CTS,有一个统计上的显着改善,突出rs-fMRI上级分类的作用。结论:RS-fMRI提供CTS MCI患者/健康对照个体的分类的补充信息。
关键词: 准确性,阿尔茨海默氏病,生物学标志,分类,轻度认知功能障碍,神经退行性变。
Current Alzheimer Research
Title:Integration of Cognitive Tests and Resting State fMRI for the Individual Identification of Mild Cognitive Impairment
Volume: 12 Issue: 6
Author(s): Leandro Beltrachini, Matteo De Marco, Zeike A. Taylor, Jyrki Lotjonen, Alejandro F. Frangi and Annalena Venneri
Affiliation:
关键词: 准确性,阿尔茨海默氏病,生物学标志,分类,轻度认知功能障碍,神经退行性变。
摘要: Background: Resting-state functional magnetic resonance imaging (RS-fMRI) appears as a promising imaging technique to identify early biomarkers of Alzheimer type neurodegeneration, which can be more sensitive to detect the earliest stages of this disease than structural alterations. Recent findings have highlighted interesting patterns of alteration in resting-state activity at the mild cognitive impairment (MCI) prodromal stage of Alzheimer’s disease. However, it has not been established whether RS-fMRI alterations may be of any diagnostic use at the individual patient level and whether parameters derived from RS-fMRI images add any quantitative predictive/classificatory value to standard cognitive tests (CTs). Methods: We computed a set of 444 features based on RS-fMRI and used 21 variables obtained from a neuropsychological assessment battery of tests in 29 MCI patients and 21 healthy controls. We used these indices to evaluate their impact on MCI/healthy control classification using machine learning algorithms and a 10-fold cross validation analysis. Results: A classification accuracy (sensitivity/ specificity/area under curve/positive predictive value/negative predictive value) of 0.9559 (0.9620/0.9470/ 0.9517/0.9720/0.9628) was achieved when using both sets of indices. There was a statistically significant improvement over the use of CTs only, highlighting the superior classificatory role of RS-fMRI. Conclusions: RS-fMRI provides complementary information to CTs for MCI-patient/healthy control individual classification.
Export Options
About this article
Cite this article as:
Leandro Beltrachini, Matteo De Marco, Zeike A. Taylor, Jyrki Lotjonen, Alejandro F. Frangi and Annalena Venneri , Integration of Cognitive Tests and Resting State fMRI for the Individual Identification of Mild Cognitive Impairment, Current Alzheimer Research 2015; 12 (6) . https://dx.doi.org/10.2174/156720501206150716120332
DOI https://dx.doi.org/10.2174/156720501206150716120332 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Is Brain-Derived Neurotrophic Factor: A Common Link Between Neurodegenerative Disorders and Cancer?
Current Alzheimer Research Dural Venous Sinuses: What We Need to Know
Current Medical Imaging FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects
Current Radiopharmaceuticals Neuroimaging of Non-Accidental Injury
Current Pediatric Reviews Targeting Strategies in Therapeutic Applications of Toxoplasmosis: Recent Advances in Liposomal Vaccine Delivery Systems
Current Drug Targets Aquaporin and Blood Brain Barrier
Current Neuropharmacology Association between HbA1C (Glycated Hemoglobin) and Clinical Outcomes in Patients with Subarachnoid Hemorrhage After Neuro-intervention
Current Neurovascular Research GSK-3 Inhibitors: A New Class of Drugs for Alzheimer’s Disease Treatment
Current Drug Targets Central Nervous System Involvement in Pediatric Rheumatic Diseases: Current Concepts in Treatment
Current Pharmaceutical Design Clinical Pharmacology of Phenobarbital in Neonates: Effects, Metabolism and Pharmacokinetics
Current Pediatric Reviews Flow Volumes of Internal Jugular Veins are Significantly Reduced in Patients with Cerebral Venous Sinus Thrombosis
Current Neurovascular Research Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets
Current Neuropharmacology In Vitro and In Vivo Models of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Onset Age and Clinical Heterogeneity of Dementias: A Diagnostic and Therapeutic Approach
Current Psychopharmacology Melatonin and Its Therapeutic Potential in Neuroprotection
Central Nervous System Agents in Medicinal Chemistry Early Timing of Endovascular Treatment for Aneurysmal Subarachnoid Hemorrhage Achieves Improved Outcomes
Current Neurovascular Research Microbial Immune Evasion Employing Suppressor of Cytokine Signaling (SOCS) Proteins
Inflammation & Allergy - Drug Targets (Discontinued) Is Helicobacter pylori the Infectious Trigger for Headache?: A Review
Infectious Disorders - Drug Targets Treatment of Viral Encephalitis
Central Nervous System Agents in Medicinal Chemistry Dorsal Stream Dysfunction in Children. A Review and an Approach to Diagnosis and Management
Current Pediatric Reviews